PACUPod: Critical Care

Clinical research summary for "propofol vs midazolam for ICU sedation": [PubMed] 10 articles found for "propofol vs midazolam for ICU sedation" (PMIDs: 22436955, 39100810, 36795623, 11296183, 9470082)

Join PACULit as we unpack a randomized clinical trial evaluating a drug-related problem oriented medical record (DAM) used during medication reviews for critically ill patients. The study, conducted in two Brazilian ICUs, randomized 150 adults likely to require mechanical ventilation or with organ dysfunction to DAM-enabled medication review versus standard practice. Primary outcome was hospital l...

In this PACULit episode, Britany and Seth discuss Keats et al.'s study that uses unsupervised machine learning on ICU intravenous medication data to identify pharmacophenotypes associated with fluid overload. By applying principal component analysis for dimensionality reduction and a restricted Boltzmann machine clustering algorithm to 72-hour medication records from 927 adults in a single ICU, th...

In this PACULit episode, Britany and Seth analyze a secondary analysis of the Pragmatic Airway Resuscitation Trial (PART) to address whether vasopressors or advanced airway placement should come first during out-of-hospital cardiac arrest. The study found no significant differences in 72-hour survival, return of spontaneous circulation, hospital survival, or neurological outcomes between the two s...

{ "episode_description": "PACUPod – PACULit Daily Literature Update\nEpisode: Antibiotic De-Escalation in the ICU – A Multicenter Observational Study\nIn this episode, we review the multicenter observational study “Antibiotic De-Escalation Practices in the Intensive Care Unit: A Multicenter Observational Study” by Patanwala, Abu Sardaneh, Alffenaar, and colleagues, published in the Annals of Pharm...

{"episode_description":"PACULit Daily Literature Update: Stress hyperglycemia ratio as a biomarker for early mortality risk stratification in cardiovascular disease — a propensity matched analysis. In this episode we review Lei and colleagues’ retrospective cohort study using the MIMIC-IV database (n=3,352) to evaluate whether the stress hyperglycemia ratio (SHR) can help predict early mortality i...

{ "episode_title": "PACUPod: Stress Dose Hydrocortisone Tapers in Septic Shock – Retrospective Cohort Review", "episode_description": "AI-powered literature briefing from PACUPod. This episode reviews a retrospective cohort study published in Hosp Pharm by Gilchrist et al., evaluating how stress-dose hydrocortisone tapers were used in 276 ICU patients with septic shock between 2020 and 2023. Key f...

{ "podcast": "PACUPod", "episode_title": "IsoCOMFORT: Inhaled isoflurane for sedation of mechanically ventilated children in intensive care", "episode_description": "A concise AI-assisted overview of the IsoCOMFORT trial (Lancet Respiratory Medicine) comparing inhaled isoflurane sedation versus intravenous midazolam in mechanically ventilated children. The episode covers study design, non-inferior...

{ "podcast": "PACUPod", "episode_title": "Machine Learning Accurately Predicts Need for Critical Care Support in Community-Acquired Pneumonia", "description": "In this PACUPod update, we summarize a retrospective observational study from Critical Care Explorations that develops machine learning models to predict the need for invasive ventilation, vasopressors, and renal replacement therapy in adul...

In this PACULit episode, the focus is on the efficacy of neuromuscular blocking agents (NMBAs) in ARDS, with emphasis on patients who have high respiratory system elastance. The discussion reviews pivotal trials (ACURASYS showing mortality benefit with early cisatracurium vs ROSE showing no clear survival advantage), explores how sedation depth and lung mechanics may influence outcomes, and highli...

This PACULit episode reviews a pharmacokinetic modeling and simulation study evaluating a cystatin C–guided dosing nomogram for cefepime in critically ill adults. By integrating cystatin C–based estimates with creatinine, the dosing strategy (eGFRcr-cys) aims to improve attainment of the pharmacodynamic target—free cefepime above the MIC for 100% of the dosing interval (fT>MIC)—over a 24-hour p...